MEPHONE 500 TABLET

Product Description

MEPHONE 500 TABLET is a premium immunosuppressive formulation containing Mycophenolate Mofetil 500mg, widely prescribed to prevent organ transplant rejectionparticularly in kidney, heart, and liver transplants. Manufactured under WHO-GMP certified facilities, MEPHONE 500 ensures reliable bioavailability, high potency, and superior patient outcomes.

Designed for hospital pharmacies, bulk medicine suppliers, and medical distributors, this formulation is trusted by nephrologists and transplant specialists across the country for its proven efficacy in suppressing immune response and promoting organ graft survival.

Key Benefits:

• Contains Mycophenolate Mofetil 500mg a standard in transplant care

• Minimizes risk of organ rejection post-transplantation

• GMP-compliant, high-quality formulation ensuring safety and consistency

• Ideal for bulk purchase, institutional supply, and hospital tenders

Applications:

• Prevents organ transplant rejection (renal, hepatic, cardiac)

• Commonly used in post-transplant immunosuppressive therapy

• Widely prescribed in nephrology, transplant units, and specialty clinics

Why Choose MEPHONE 500 TABLET?

• Trusted choice for transplant care protocols

• Available for bulk procurement and third-party manufacturing

• Pan-India supply capability with excellent distributor margins